Merck delivers vital data on evobrutinib
24th February 2023 Uncategorised 0Treatment is an BTK inhibitor and has demonstrated a sound safety and tolerability profile
More: Merck delivers vital data on evobrutinib
Source: News
Treatment is an BTK inhibitor and has demonstrated a sound safety and tolerability profile
More: Merck delivers vital data on evobrutinib
Source: News
© 1994 - 2026 B.M. Pharmaceuticals